Arnika Rehbein

1.0k total citations
50 papers, 838 citations indexed

About

Arnika Rehbein is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Arnika Rehbein has authored 50 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 19 papers in Oncology and 7 papers in Hematology. Recurrent topics in Arnika Rehbein's work include Immune Cell Function and Interaction (34 papers), T-cell and B-cell Immunology (31 papers) and Immunotherapy and Immune Responses (17 papers). Arnika Rehbein is often cited by papers focused on Immune Cell Function and Interaction (34 papers), T-cell and B-cell Immunology (31 papers) and Immunotherapy and Immune Responses (17 papers). Arnika Rehbein collaborates with scholars based in Germany, Australia and France. Arnika Rehbein's co-authors include Graham Pawelec, Medi Adibzadeh, Peter Wernet, Kurt Schaudt, Heike Pohla, Graham Pawelec, Karin Hähnel, E. M. Schneider, David M. Sansom and Claude P. Muller and has published in prestigious journals such as The Journal of Immunology, Immunological Reviews and European Journal of Immunology.

In The Last Decade

Arnika Rehbein

49 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnika Rehbein Germany 18 609 159 142 128 106 50 838
William D. Ratnoff United States 15 433 0.7× 50 0.3× 92 0.6× 188 1.5× 126 1.2× 18 777
J B Innes United States 11 764 1.3× 66 0.4× 89 0.6× 109 0.9× 146 1.4× 13 968
Liliana Calosso Italy 10 457 0.8× 161 1.0× 141 1.0× 135 1.1× 37 0.3× 10 920
Jian‐Guo Chai United Kingdom 21 1.1k 1.7× 257 1.6× 51 0.4× 193 1.5× 60 0.6× 38 1.3k
C Morimoto United States 11 540 0.9× 100 0.6× 59 0.4× 135 1.1× 245 2.3× 13 832
C Dubois France 12 428 0.7× 137 0.9× 63 0.4× 404 3.2× 45 0.4× 13 913
Samuel D. Waksal United States 15 324 0.5× 91 0.6× 47 0.3× 132 1.0× 63 0.6× 40 579
AR Dunn Australia 5 610 1.0× 255 1.6× 88 0.6× 173 1.4× 14 0.1× 7 952
Jesse L. Gurgel United States 5 429 0.7× 176 1.1× 68 0.5× 97 0.8× 75 0.7× 6 700
Toshifumi Mikayama Japan 15 685 1.1× 133 0.8× 113 0.8× 111 0.9× 42 0.4× 23 935

Countries citing papers authored by Arnika Rehbein

Since Specialization
Citations

This map shows the geographic impact of Arnika Rehbein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnika Rehbein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnika Rehbein more than expected).

Fields of papers citing papers by Arnika Rehbein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnika Rehbein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnika Rehbein. The network helps show where Arnika Rehbein may publish in the future.

Co-authorship network of co-authors of Arnika Rehbein

This figure shows the co-authorship network connecting the top 25 collaborators of Arnika Rehbein. A scholar is included among the top collaborators of Arnika Rehbein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnika Rehbein. Arnika Rehbein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pawelec, Graham, et al.. (2005). Immunosenescence, suppression and tumour progression. Cancer Immunology Immunotherapy. 55(8). 981–986. 40 indexed citations
2.
Pawelec, Graham, Medi Adibzadeh, Arnika Rehbein, et al.. (2000). In vitro senescence models for human T lymphocytes. Vaccine. 18(16). 1666–1674. 30 indexed citations
3.
Pawelec, Graham, Robert Müller, Arnika Rehbein, Karin Hähnel, & Benedikt Ziegler. (1999). Finite lifespans of t cell clones derived from CD34+ human haematopoietic stem cells in vitro. Experimental Gerontology. 34(1). 69–77. 9 indexed citations
4.
Pawelec, Graham, et al.. (1997). Human T‐cell clones in long‐term culture as a model of immunosenescence. Immunological Reviews. 160(1). 31–42. 79 indexed citations
5.
Pawelec, Graham, David M. Sansom, Arnika Rehbein, Medi Adibzadeh, & Ian Beckman. (1996). Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human cd4+ tcr2+ cultured T cell clones. Experimental Gerontology. 31(6). 655–668. 55 indexed citations
6.
Pawelec, Graham, et al.. (1996). Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro. Cancer Immunology Immunotherapy. 42(3). 193–199. 27 indexed citations
7.
Pawelec, Graham, et al.. (1996). CYTOKINE MODULATION OF TH1/TH2 PHENOTYPE DIFFERENTIATION IN DIRECTLY ALLORESPONSIVE CD4+ HUMAN T CELLS1. Transplantation. 62(8). 1095–1101. 21 indexed citations
8.
Pawelec, Graham, Martina Boshell, Arnika Rehbein, et al.. (1995). Human γδ Cells Are Resistant to Induction of Anergy but Not to Induction of Cell Death in Vitro. Cellular Immunology. 162(1). 8–15. 4 indexed citations
9.
Pawelec, Graham, Hubert Kalbacher, Helmuth Schmidt, et al.. (1995). Relative Roles of Natural Killer- and T Cell-Mediated Anti-Leukemia Effects in Chronic Myelogenous Leukemia Patients Treated with Interferon-α. Leukemia & lymphoma. 18(5-6). 471–478. 32 indexed citations
10.
Pawelec, Graham, et al.. (1995). Interleukin 10 is a human T cell growth factor in vitro. Cytokine. 7(4). 355–363. 11 indexed citations
11.
Rehbein, Arnika, et al.. (1993). Induction of Hyporesponsiveness in Human Lymphocytes-T Despite Their Expression of both the Co-receptor CD28 and Its Ligand B7. Cellular Immunology. 151(2). 283–290. 4 indexed citations
13.
Pawelec, Graham, Petra Baumgärtner, Arnika Rehbein, Uwe Reusch, & Kurt Schaudt. (1990). CYTOKINE REGULATION OF THE BALANCE BETWEEN ALLOINDIFFERENT AND ALLOSPECIFIC SUPPRESSOR INDUCTION IN MIXED LYMPHOCYTE CULTURES. Transplantation. 49(3). 615–618. 8 indexed citations
14.
Pawelec, Graham, et al.. (1989). Frequencies of HLA‐DP alleles in the four major types of leukaemia. Tissue Antigens. 34(2). 138–140. 6 indexed citations
16.
17.
Pawelec, Graham, P. Reekers, D. Brackertz, et al.. (1988). HLA‐DP in rheumatoid arthritis. Tissue Antigens. 31(2). 83–89. 27 indexed citations
18.
Pawelec, Graham, et al.. (1988). Division of human helper T cells into two sets on the basis of the induction of anti‐tumor cytotoxicity by phorbol ester and calcium ionophore. European Journal of Immunology. 18(7). 1147–1150. 7 indexed citations
19.
Pawelec, Graham, et al.. (1984). Alloproliferative human T cell clones primed and cultured in vitro lose proliferative and gain suppressive activity with age. Human Immunology. 10(2). 135–142. 9 indexed citations
20.
Pawelec, Graham, M. Hadam, Andreas Ziegler, et al.. (1982). Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity.. The Journal of Immunology. 128(4). 1892–1896. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026